Inflazyme Pharmaceuticals Ltd.: Shareholder Letter and Financial Results for the Quarter Ended September 30, 2006
15th Nov 2006, 03:53 GMT
Inflazyme Pharmaceuticals Ltd. (TSX: IZP) today announced its second quarter financial results for the period ended September 30, 2006. Dear...
Inflazyme Pharmaceuticals Ltd.: Shareholder Letter and Financial Results for the Quarter Ended September 30, 2006 related news:
- Inflazyme Pharmaceuticals Ltd.: Inflazyme Pharmaceuticals Ltd.: Shareholder Letter and Financial Results for the Quarter Ended September 30, 2006 — Market Wire - Pharmaceuticals and Biotech
- Symbollon Pharmaceuticals Announces Third Quarter 2006 Results — ArriveNet : Health
- Symbollon Pharmaceuticals, Inc.: Symbollon Pharmaceuticals Announces Third Quarter 2006 Results — Market Wire - Pharmaceuticals and Biotech
- Vector Group Reports Third Quarter 2006 Financial Results — Nachrichten Ticker - www.finanzen.net
- Silverstar Holdings Announces Financial Results for Period Ending September 30, 2006 — ArriveNet : Business
- Loring Ward International Ltd.: Loring Ward Third Quarter Results Conference Call — Market Wire - Financial Services
- Diaz Resources Ltd.: Diaz Reports Financial & Operating Results for First Nine Months of 2006 — Market Wire - Energy and Utilities
- Idera Pharmaceuticals Announces Financial Results for the 3 and 9 Months Ended 9/30/2006 — Operations-Related News from StratCenter.com
- Jaclyn Reports First Quarter Financial Results; Announces Developments Concerning Purchase Option on West New York Facility — ArriveNet : Press Releases
- Excel Maritime: Excel Maritime Reports Results for the Third Quarter and Nine Month Period Ended September 30, 2006 — Market Wire - Earnings Reports
Latest news from ArriveNet : Health:
- Gold Reserve announces improved Brisas Project economics and updates Brisas Project 43-101 Report
- PuriCore Plc announces Appointment
- Lisa Zuckerman Joins Catholic Healthcare West as Vice President of Treasury Services
- ORLive Presents: Minimally Invasive Aortic Valve Replacement Surgery -- Increasingly Popular Procedure to Correct Heart Function
- Adult Stem Cells Have Ability to Develop and Replicate Like Embryonic Stem Cells
- Extraordinary general meeting of Precise Biometrics AB approves of new share issue with preferential rights for shareholders of approximately SEK 85 million
- Invitation Conference Call Analyst Meeting
- IBEX: Analysis of Urinary C2C Distinguishes Between Individuals with Painful Knees and Individuals Identified by MRI to Have Early Osteoarthritis
- YES Secures 100 Country Distribution Deal, Announces First Int'l Shipments Begin
- Lenstec Receives FDA Clearance to Begin Clinical Trial of Softec HD IOL